Second COVID-19 Vaccine Study Paused: Should You Worry?
Last week Johnson & Johnson announced that they were temporarily pausing their COVID-19 vaccine clinical studies in order to review and evaluate an unexpected illness in an individual participating in their study, less than 3 weeks after their Phase 3 study had started. Another COVID-19 vaccine, developed by the University of Oxford, also had its clinical studies paused in July and September for similar reasons. Read on for my thoughts on what this may mean for potential COVID-19 vaccines and their safety.